We performed ChIPseq using HCT116 colon carcinoma cells, identifying ~850 putative target genes associated with metabolism (e.g., Prdx5, Mdh1, Ahcy), transcription (Taf12, Tet2, histones), malignancy (Met, Blcap, Rras, Jag1, Gsk3a) and mitotic stability (Zbtb4). The gene discussed is PRDX5; the disease is colon carcinoma.